# Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury

> **NCT06836856** · PHASE1,PHASE2 · RECRUITING · sponsor: **Mansoura University** · enrollment: 100 (estimated)

## Conditions studied

- TBI Traumatic Brain Injury

## Interventions

- **DRUG:** control
- **DRUG:** propranolol
- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT06836856
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06836856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06836856, "Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06836856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*